Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC), 47003 Valladolid, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain.
Molecules. 2022 Apr 6;27(7):2347. doi: 10.3390/molecules27072347.
Group IVA cytosolic phospholipase Aα (cPLAα) is a key enzyme in physiology and pathophysiology because it constitutes a rate-limiting step in the pathway for the generation of pro- and anti-inflammatory eicosanoid lipid mediators. cPLAα activity is tightly regulated by multiple factors, including the intracellular Ca concentration, phosphorylation reactions, and cellular phosphatidylinositol (4,5) bisphosphate levels (PtdInsP). In the present work, we demonstrate that phosphorylation of the enzyme at Ser is an important step for the translocation of the enzyme to PtdInsP-enriched membranes in human cells. Constructs of eGFP-cPLA mutated in Ser to Ala (S505A) exhibit a delayed translocation in response to elevated intracellular Ca, and also in response to increases in intracellular PtdInsP levels. Conversely, translocation of a phosphorylation mimic mutant (S505E) is fully observed in response to cellular increases in PtdInsP levels. Collectively, these results suggest that phosphorylation of cPLAα at Ser is necessary for the enzyme to translocate to internal membranes and mobilize arachidonic acid for eicosanoid synthesis.
IV 型胞质型磷脂酶 Aα(cPLAα)是生理和病理生理学中的关键酶,因为它构成了生成促炎和抗炎类花生酸脂质介质途径中的限速步骤。cPLAα 的活性受到多种因素的严格调节,包括细胞内 Ca 浓度、磷酸化反应和细胞磷脂酰肌醇(4,5)二磷酸水平(PtdInsP)。在本工作中,我们证明了酶在丝氨酸的磷酸化是酶向富含 PtdInsP 的人细胞膜易位的重要步骤。在 Ser 突变为 Ala(S505A)的 eGFP-cPLA 构建体中,响应升高的细胞内 Ca 以及细胞内 PtdInsP 水平的增加,显示出延迟的易位。相反,磷酸化模拟突变体(S505E)的易位完全响应细胞内 PtdInsP 水平的增加而发生。总的来说,这些结果表明 cPLAα 在 Ser 的磷酸化对于酶向内部膜易位和动员花生四烯酸用于类花生酸合成是必要的。